TNF and rheumatoid arthritis: Data sustaining a pivotal role for TNF-α in RA pathology in humans have arisen from several studies showing that the therapeutic blockade of TNF-α with neutralizing antibodies, such as infliximab and adalimumab, provides significant clinical benefit for RA patients [22].